Allosteric modulators of G-protein-coupled receptors

Current Opinion in Pharmacology

Volumn 3, Issue 5, 2003, Pages 551-556

  May, Lauren T ^a   Christopoulos, Arthur ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 METHOXYPHENYL) N (3 PHENYLPROPYL)ETHYLAMINE; 2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; 4 AMINOBUTYRIC ACID B RECEPTOR; ACETYLSALICYLIC ACID; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; AGMATINE; ALCURONIUM; AMILORIDE DERIVATIVE; AMINO ACID; BENZODIAZEPINE DERIVATIVE; BRUCINE; CALCIUM SENSING RECEPTOR; CHEMOKINE RECEPTOR; DOPAMINE 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR; GALLAMINE; HEPARIN; LEUCYLSERYLALANYLLEUCINE; N [3 (2 CHLOROPHENYL)PROPYL] 1 (3 METHOXYPHENYL)ETHYLAMINE; OLEAMIDE; PRENYLAMINE; PROLYLLEUCYLGLYCINAMIDE; RADIOLIGAND; SALICYLATE SODIUM; TOLUENESULFONIC ACID DERIVATIVE; TRICHOSANTHIN; UNINDEXED DRUG; ZINC;

ALLOSTERISM; BINDING SITE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG SELECTIVITY; DRUG TARGETING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; RADIOASSAY; REVIEW; TOPOGRAPHY; VALIDATION PROCESS;

ALLOSTERIC REGULATION; ALLOSTERIC SITE; ANIMALS; BINDING, COMPETITIVE; DRUG DESIGN; HUMANS; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED; TECHNOLOGY, PHARMACEUTICAL;

EID: 0141869933     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(03)00107-3     Document Type: Review

References (39)

1. Drews J. Drug discovery: a historical perspective Science 287 2000 1960-1964
2. Christopoulos A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery Nat Rev Drug Discov 1 2002 198-210
3. Denyer J. Worley J. Cox B. Allenby G. Banks M. HTS approaches to voltage-gated ion channel drug discovery Drug Discov Today 3 1998 323-332
4. Clare J.J. Tate S.N. Nobbs M. Romanos M.A. Voltage-gated sodium channels as therapeutic targets Drug Discov Today 5 2000 506-520
5. Maelicke A, Albuquerque EX: Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease. Eur J Pharmacol 2000, 393:165-170.
6. Pereira E.F. Hilmas C. Santos M.D. Alkondon M. Maelicke A. Albuquerque E.X. Unconventional ligands and modulators of nicotinic receptors J Neurobiol 53 2002 479-500
7. Milligan G. Receptors as kissing cousins Science 288 2000 65-67
8. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors Nat Rev Neurosci 2 2001 274-286
9. Devi L.A. Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking Trends Pharmacol Sci 22 2001 532-537
10. Hamm H.E. The many faces of G protein signaling J Biol Chem 273 1998 669-672
11. Christopoulos A. Kenakin T. G-protein-coupled receptor allosterism and complexing Pharmacol Rev 54 2002 323-374
12. Stockton J.M. Birdsall N.J.M. Burgen A.S.V. Hulme E.C. Modification of the binding properties of muscarinic receptors by gallamine Mol Pharmacol 23 1983 551-557
13. Ehlert F.J. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods Mol Pharmacol 33 1988 187-194
14. Lazareno S. Birdsall N.J.M. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors Mol Pharmacol 48 1995 362-378
15. Christopoulos A: Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays. In Current Protocols in Pharmacology. Edited by Enna SJ. New York: Wiley and Sons; 2000:1.22.21-21.22.40.
16. 7/3-phth) at cloned muscarinic acetylcholine receptors Biochem Pharmacol 57 1999 171-179
17. Zahn K. Eckstein N. Trankle C. Sadee W. Mohr K. Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist J Pharmacol Exp Ther 301 2002 720-728
18. Litschig S. Gasparini F. Rueegg D. Stoehr N. Flor P.J. Vranesic I. Prezeau L. Pin J.P. Thomsen C. Kuhn R. CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding Mol Pharmacol 55 1999 453-461
19. Pagano A. Ruegg D. Litschig S. Stoehr N. Stierlin C. Heinrich M. Floersheim P. Prezeau L. Carroll F. Pin J.P. et al. The non-competitive antagonists 2-methyl-6-(phenylethynyl)pyridine and 7-hydroxyiminocyclopropan[b]chromen-1a-carboxylic acid ethyl ester interact with overlapping binding pockets in the transmembrane region of group I metabotropic glutamate receptors J Biol Chem 275 2000 33750-33758
20. Knoflach F. Mutel V. Jolidon S. Kew J.N. Malherbe P. Vieira E. Wichmann J. Kemp J.A. Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site Proc Natl Acad Sci USA 98 2001 13402-13407
21. Urwyler S. Mosbacher J. Lingenhoehl K. Heid J. Hofstetter K. Froestl W. Bettler B. Kaupmann K. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501 Mol Pharmacol 60 2001 963-971
22. Jakubík J. Bacakova L. Lisa V. El-Fakahany E.E. Tucek S. Activation of muscarinic acetylcholine receptors via their allosteric binding sites Proc Natl Acad Sci USA 93 1996 8705-8709
23. Thomas E.A. Carson M.J. Neal M.J. Sutcliffe J.G. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide Proc Natl Acad Sci USA 94 1997 14115-14119
24. Sachpatzidis A. Benton B.K. Manfredi J.P. Wang H. Hamilton A. Dohlman H.G. Lolis E. Identification of allosteric peptide agonists of CXCR4 J Biol Chem 278 2003 896-907
25. Lazareno S. Gharagozloo P. Kuonen D. Popham A. Birdsall N.J.M. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies Mol Pharmacol 53 1998 573-589
26. Birdsall N.J. Lazareno S. Matsui H. Allosteric regulation of muscarinic receptors Prog Brain Res 109 1996 147-151
27. 2 receptors Mol Pharmacol 54 1998 139-145
28. 2 receptors Mol Pharmacol 56 1999 962-965
29. 3H]R214127: a novel high-affinity radioligand for the mGlu1 receptor reveals a common binding site shared by multiple allosteric antagonists Mol Pharmacol 63 2003 1082-1093
30. Kostenis E. Mohr K. Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation Trends Pharmacol Sci 17 1996 280-283
31. Rees S. Morrow D. Kenakin T. GPCR drug discovery through the exploitation of allosteric drug binding sites Receptors Channels 8 2002 261-268
32. Chalmers D.T. Behan D.P. The use of constitutively active GPCRs in drug discovery and functional genomics Nat Rev Drug Discov 1 2002 599-608
33. 2+ receptor expressed in Xenopus laevis oocytes by NPS 467 or NPS 568 Mol Pharmacol 53 1998 1083-1088
34. Nemeth E.F. Steffey M.E. Hammerland L.G. Hung B.C. Van Wagenen B.C. DelMar E.G. Balandrin M.F. Calcimimetics with potent and selective activity on the parathyroid calcium receptor Proc Natl Acad Sci USA 95 1998 4040-4045
35. Gasparini F. Lingenhohl K. Stoehr N. Flor P.J. Heinrich M. Vranesic I. Biollaz M. Allgeier H. Heckendorn R. Urwyler S. et al. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist Neuropharmacology 38 1999 1493-1503
36. Carroll F.Y. Stolle A. Beart P.M. Voerste A. Brabet I. Mauler F. Joly C. Antonicek H. Bockaert J. Muller T. et al. BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity Mol Pharmacol 59 2001 965-973
37. 2 receptors Mol Pharmacol 64 2003 180-190
38. Sharpe I.A. Gehrmann J. Loughnan M.L. Thomas L. Adams D.A. Atkins A. Palant E. Craik D.J. Adams D.J. Alewood P.F. et al. Two new classes of conopeptides inhibit the α1-adrenoceptor and noradrenaline transporter Nat Neurosci 4 2001 902-907
39. Kollias-Baker C. Ruble J. Dennis D. Bruns R.F. Linden J. Belardinelli L. Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine Circ Res 75 1994 961-971